MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0000797
Evertogen Life Sciences Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹89.28 Cr
▲ 51% YoY
Net loss · FY 2024
₹8.52 Cr
Net margin -9.5%
EBITDA · FY 2024
₹3.68 Cr
EBITDA margin 4.1%
Authorised capital
₹122 Cr
Registered with MCA
Paid-up capital
₹119.14 Cr
Issued & subscribed
Open charges
₹135.17 Cr
Satisfied ₹36.51 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
265
Provident fund records
About Evertogen Life Sciences Limited
Data last updated:
Evertogen Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Glochem Industries Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PLC085349. Its GSTIN is 36AABCO7786R1ZE (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹122 Cr and a paid-up capital of ₹119.14 Cr. It was formerly known as Optimus Generics Limited. It is led by directors including Subbarao Kattamuri (Managing Director) and Manav Jassal.
Its last annual general meeting (AGM) was held on 09 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 7 – 2 – C8 & C8/2 G V Chambers Sanath Nagar Ida Sanath Nagar, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2024, the company reported a revenue of ₹89.28 Cr, a growth of 51% compared to the previous year. For the same year it recorded a net loss of ₹8.52 Cr (net margin -9.5%) and EBITDA of ₹3.68 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
The company has about 265 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Evertogen Life Sciences. As per MCA filings, the company has open charges of ₹135.17 Cr and satisfied charges of ₹36.51 Cr on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it; 1 case is pending. The company has 22 deals on record (7 funding rounds, 6 rights issues, 4 debt financings), with disclosed funding of ₹95.27 Cr; the latest was in March 2022. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Shrey Nutraceuticals and Herbals Private Limited with revenue of ₹89.53 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2024, listing 805 overdue payments to 111 micro and small suppliers.
Evertogen Life Sciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0000797). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evertogen.com.
Company details
CIN U24232TG2013PLC085349
Registration Number 085349
Incorporation Date 11 January 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 09 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Glochem Industries Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0000797
CIN history
Evertogen Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2013PLC085349. The current CIN is U24232TG2013PLC085349, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PLC085349 | Current |
| U24232AP2013PLC085349 | Previous |
Key People
Subbarao Kattamuri Managing Director Manav Jassal Director Sherifuddin Sheriff Shaik Director Recognitions & Rankings of Evertogen Life Sciences
Contact details
Evertogen Life Sciences Limited's registered office is in Hyderabad, Telangana. Its website is evertogen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address7 – 2 – C8 & C8/2 G V Chambers Sanath Nagar Ida Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Evertogen Life Sciences Limited, buy the company report.
Comprehensive company report
Evertogen Life Sciences Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Evertogen Life Sciences operates one associated brand: Evertogen Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality pharmaceutical products for global markets with safety emphasis. | evertogen.com |
Business activity
The main business activity of Evertogen Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Evertogen Life Sciences Limited, buy the company report.
Financials of Evertogen Life Sciences Limited
FY 2024 filings availableEvertogen Life Sciences Limited reported revenue of ₹89.28 Cr (up 51% YoY) for FY 2024.
Revenue · FY 2024
₹89.28 Cr ▲ 51%
Net loss · FY 2024
₹8.52 Cr margin -9.5%
EBITDA · FY 2024
₹3.68 Cr margin 4.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 9%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 204%
3 years · compounded
▲ 16%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 51% growth in the latest year. EBITDA rose 204% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | -9.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evertogen Life Sciences Limited, buy the company report.
Board of directors of Evertogen Life Sciences Limited
Evertogen Life Sciences has 6 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manav Jassal | Director | 11 Jan 2013 | 13 Years 9 Months | Current |
| Subbarao Kattamuri | Managing Director | 11 Jan 2013 | 13 Years 9 Months | Current |
| Sherifuddin Sheriff Shaik | Director | 06 Dec 2023 | 2 Years 10 Months | Current |
| Vikram Ravindra Mamidipudi Also directs: Ahlada Engineers Limited, Sai Silks (Kalamandir) Limited, Asm Technologies Limited and 5 more | Director | 27 Mar 2015 | 11 Years 6 Months | Current |
| Sushma Kattamuri | Director | 05 Jan 2022 | 4 Years 9 Months | Current |
| Sat Paul Jassal Also directs: Organosyn Life Sciences Private Limited | Director | 18 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Evertogen Life Sciences Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shrey Nutraceuticals and Herbals Private Limited | ₹89.53 Cr (FY 2025) | 263.0% | New Delhi, Delhi, India | |||
| Verdant Life Sciences Private Limited | ₹89.48 Cr (FY 2025) | 6.0% | Andhra Pradesh, India | |||
| Sam Fine O Chem Limited | ₹89.46 Cr (FY 2025) | 22.0% | Rajkot, Gujarat, India | |||
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | -2.0% | Indore, Madhya Pradesh, India | |||
| Evertogen Life Sciences Limitedthis company | ₹89.28 Cr (FY 2024) | -₹8.52 Cr | -9.5% | 51.0% | 265 | Hyderabad, Telangana, India |
| U S Pharma (India) Private Limited | ₹89.26 Cr (FY 2025) | 421.0% | Mumbai, Maharashtra, India | |||
| Gnosis Pharmaceuticals Private Limited | ₹88.76 Cr (FY 2024) | 18.0% | New Delhi, Delhi, India | |||
| Martin & Brown Bio-Sciences Private Limited | ₹88.52 Cr (FY 2025) | 75.0% | Nalagarh, Himachal Pradesh, India | |||
| Ravian Life Science Private Limited | ₹88.41 Cr (FY 2025) | 2.0% | Haridwar, Uttarakhand, India | |||
| SRS Pharmaceuticals Private Limited | ₹88.26 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Evertogen Life Sciences Limited, buy the company report.
Auditor
Evertogen Life Sciences Limited is audited by M Bhaskara Rao & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M Bhaskara Rao & Co | FY 2023 | 000459S |
Shareholding
The shareholding of Evertogen Life Sciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Evertogen Life Sciences Limited, buy the company report.
Charges & borrowings
Open charges
₹135.17 Cr
Satisfied charges
₹36.51 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Apr 2022 | 100568530 | Hdfc Bank Limited | ₹37.3 Cr | Open | |
| 16 Sep 2020 | 100371609 | Axis Bank Limited | ₹5.2 Cr | Open | |
| 25 Aug 2020 | 100386423 | Others | ₹2.87 Cr | Open | |
| 07 Feb 2014 | 10477914 | Axis Bank Limited | ₹89.8 Cr | Open | |
| 29 Mar 2022 | 100573842 | Others | ₹20 Cr | Satisfied |
To see the full charge records of Evertogen Life Sciences Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Evertogen Life Sciences Limited has 22 deals on record (7 funding rounds, 6 rights issues, 4 debt financings), with disclosed funding of ₹95.27 Cr; the latest was in March 2022.
Total deals
22
Funding rounds
7
Rights issues
6
Debt financings
4
Acquisitions
4
Disclosed funding
₹95.27 Cr
Deals on record (5 of 22)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: Glochem Industries Private Limited Seller: Gil Agrotech ( India ) Private Limited |
| Jan 2022 | Funding round | ₹22.76 Cr | Investors: Glochem Industries Private Limited, Organosyn Life Sciences Private Limited |
| Oct 2019 | Rights issue | ₹23.15 Cr | Investors: Glochem Industries Private Limited, Organosyn Life Sciences Private Limited |
| Mar 2018 | Rights issue | ₹10.22 Cr | Investors: Glochem Industries Private Limited, Organosyn Life Sciences Private Limited |
| Jun 2017 | Rights issue | ₹1.37 Cr | Investors: Organosyn Life Sciences Private Limited |
To see the full deal history of Evertogen Life Sciences Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Evertogen Life Sciences Limited has 7 court cases on record: 1 filed by Evertogen Life Sciences, 6 filed against it. 1 case is pending and 6 are disposed.
Total cases
7
Filed by the company
1
Filed against the company
6
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 0 |
| High courts | 2 | 1 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mahabubnagar, Telangana | Civil suit | Filed against the company by M/Sjasper Industries Private Ltd | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against The Transmission Corporation, and 4 Others and 4 others | Pending |
| High Court, TELANGANA | Writ petition | Filed against the company by an individual | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Meghmani LLP - Chandmal Sukhlalalji Champawat | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Meghmani LLP - Chandmal Sukhlalalji Champawat | Disposed |
To see the full case history of Evertogen Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Evertogen Life Sciences Limited was last rated by Crisil on 30 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 30 Nov 2020 |
To see the full credit ratings and regulatory alerts of Evertogen Life Sciences Limited, buy the company report.
MSME payment delays
Evertogen Life Sciences Limited has 7 MSME Form 1 returns on record between 2019 and 2024, listing 805 overdue payments to 111 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 111)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Sudeep Pharma Limited | |||
| Anish Pharmaequip Private Limited | |||
| an individual supplier | |||
| Innovative Coatings |
To see the full MSME payment records of Evertogen Life Sciences Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Evertogen Life Sciences has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Evertogen Life Sciences Limited has a workforce of 265 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
265
Active EPFO establishments
1
Employee growth
8.16%
GST
Evertogen Life Sciences has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCO7786R1ZE | Telangana | Active | 01 Jul 2017 |
| 36AABCO7786R2ZD | Telangana | Active | 06 Feb 2018 |
| 27AABCO7786R1ZD | Maharashtra | Active | 31 Mar 2021 |
To see the full GST registrations and return filing status of Evertogen Life Sciences Limited, buy the company report.
Recent activity
Evertogen Life Sciences Limited has 17 board changes on record since 2013: 6 appointments and 11 cessations. The latest: Sherifuddin Sheriff Shaik was appointed as Director on 06 Dec 2023.
Charges
A charge registered on 29 Mar 2022 via Charge ID 100573842 with Others was fully satisfied on 01 Oct 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 37.30 Cr registered on 18 Apr 2022 with Charge ID 100568530 was modified on 23 Sep 2024.
AGM
Evertogen Life Sciences Limited last Annual general meeting of members was held on 09 Sep 2024 as per latest MCA records.
Filing
Evertogen Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Sherifuddin Sheriff Shaik was appointed as Director.
Ceased
Ashok Reddy Bodanapu ceased to be Director.
Charges
A charge with Others of Rs. 20.00 Cr registered on 29 Mar 2022 with Charge ID 100573842 was modified on 03 Sep 2022.
Charges
A charge registered on 10 Feb 2021 via Charge ID 100416546 with Others was fully satisfied on 14 Jul 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 37.30 Cr with Charge ID 100568530 was registered on 18 Apr 2022.
Ceased
Kalyan Nagururu ceased to be Director.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100573842 was registered on 29 Mar 2022.
Ceased
Asfia Moin ceased to be Company Secretary.
23 earlier events are in the company report.
Frequently asked questions
Evertogen Life Sciences is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2013 (13+ years old) and is registered under CIN U24232TG2013PLC085349.
Evertogen Life Sciences has 6 current directors:
- Subbarao Kattamuri - Managing Director
- Manav Jassal - Director
- Sherifuddin Sheriff Shaik - Director
- Vikram Ravindra Mamidipudi - Director
- Sushma Kattamuri - Director
- Sat Paul Jassal - Director
The latest financial statements of Evertogen Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 09 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Evertogen Life Sciences is 36AABCO7786R1ZE, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AABCO7786R2ZD (Telangana), 27AABCO7786R1ZD (Maharashtra).
The CIN (Corporate Identification Number) of Evertogen Life Sciences is U24232TG2013PLC085349. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evertogen Life Sciences has 7 court cases on record: 1 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
Evertogen Life Sciences was incorporated on 11 January 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Evertogen Life Sciences has 22 deals on record (7 funding rounds, 6 rights issues, 4 debt financings), with disclosed funding of ₹95.27 Cr; the latest was in March 2022.
The peers of Evertogen Life Sciences by revenue are Shrey Nutraceuticals and Herbals Private Limited, Verdant Life Sciences Private Limited, Sam Fine O Chem Limited, Medilux Laboratories Pvt Ltd, U S Pharma (India) Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sherifuddin Sheriff Shaik was appointed as Director on 06 Dec 2023. Ashok Reddy Bodanapu ceased to be Director on 23 Sep 2022. Kalyan Nagururu ceased to be Director on 31 Mar 2022. Evertogen Life Sciences has 17 board changes on record in total.
Yes, Evertogen Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0000797).
Evertogen Life Sciences has 7 MSME Form 1 returns on record between 2019 and 2024, listing 805 overdue payments to 111 micro and small suppliers. The latest return was filed on 29 Apr 2024.